02688nam 2200565Ia 450 99632022330331620230721015959.01-282-69713-7978661269713592-4-068512-X(CKB)2670000000033540(EBL)557633(OCoLC)650859957(SSID)ssj0000419097(PQKBManifestationID)11251989(PQKBTitleCode)TC0000419097(PQKBWorkID)10378119(PQKB)10421859(MiAaPQ)EBC557633(Au-PeEL)EBL557633(CaPaEBR)ebr10404019(CaONFJC)MIL269713(EXLCZ)99267000000003354020090102d2009 uy 0engur|n|---|||||txtccrGuidelines for the psychosocially assisted pharmacological treatment of opioid dependence[electronic resource]Geneva, Switzerland World Health Organization20091 online resource (132 p.)Description based upon print version of record.92-4-154754-5 Includes bibliographical references (p. 96-111).COVER; TITLE; COPYRIGHT; Contents; Acknowledgements; Abbreviations and acronyms; Executive summary; Summary of recommendations; 1 Scope and purpose; 2 Method of formulating recommendations; 3 Background; 4 Guidelines for health systems at national and subnational levels; 5 Programme level guidelines - for programme managers and clinical leaders; 6 Patient level guidelines - for clinicians; AnnexESThese Guidelinesreview the use of medicines such as methadone, buprenorphine, naltrexone and clonidine in combination with psychosocial support in the treatment of people dependent on heroin or other opioids. Based on systematic reviews of the literature and using the GRADE approach to determining evidence quality, the guidelines contain specific recommendations on the range of issues faced in organizing treatment systems, managing treatment programmes and in treating people dependent on opioids. Developed in collaboration with internationally acclaimed experts from the different regions of thOpioid abuseDrug abuseOpioid abuse.Drug abuse.616.8632061World Health Organization.MiAaPQMiAaPQMiAaPQBOOK996320223303316Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence2064785UNISA